Author:
Xu Xiao-yan,Lin Ni,Li Yu-mei,Zhi Cheng,Shen Hong
Subject
Cell Biology,Pathology and Forensic Medicine
Reference36 articles.
1. Lung cancer-time to move on from chemotherapy;Carney;N. Engl. J. Med.,2002
2. Z.N. Chen, P. Shang, Y. Li, et al., NTD Patent & Trademark Agency Ltd., Beijing office, assignee. HAb18G/CD147, its agonist and application. Chinese patent ZL01131735.3, September 28 2001; PCT international patent WO02/094875.27 May 2002.
3. Direct cell–cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP;Suzuki;Exp. Cell Res.,2004
4. Receptor activator of NF-κB Ligand Enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/cd147;Rucci;Cancer Res.,2010
5. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection;Li;Histopathology,2009
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献